Authors:
GASTER LM
BLANEY FE
DAVIES S
DUCKWORTH DM
HAM P
JENKINS S
JENNINGS AJ
JOINER GF
KING FD
MULHOLLAND KR
WYMAN PA
HAGAN JJ
HATCHER J
JONES BJ
MIDDLEMISS DN
PRICE GW
RILEY G
ROBERTS C
ROUTLEDGE C
SELKIRK J
SLADE PD
Citation: Lm. Gaster et al., THE SELECTIVE 5-HT1B RECEPTOR INVERSE AGONIST TETRAHYDROSPIRO[FURO[2,3-F]INDOLE-3,4'-PIPERIDINE] (SB-224289) POTENTLY BLOCKS TERMINAL 5-HT AUTORECEPTOR FUNCTION BOTH IN-VITRO AND IN-VIVO, Journal of medicinal chemistry, 41(8), 1998, pp. 1218-1235
Authors:
ROBERTS C
BELENGUER A
MIDDLEMISS DN
ROUTLEDGE C
Citation: C. Roberts et al., DIFFERENTIAL-EFFECTS OF 5-HT1B (1D) RECEPTOR ANTAGONISTS IN DORSAL AND MEDIAN RAPHE INNERVATED BRAIN-REGIONS/, European journal of pharmacology, 346(2-3), 1998, pp. 175-180
Citation: T. Ashmeade et C. Routledge, THE ROLE OF 5-HT1B, RECEPTORS IN THE MODULATION OF PLASMA ACTH LEVELS, British Journal of Pharmacology, 123, 1998, pp. 184-184
Citation: C. Routledge, A MATTER OF DISGUISE - LOCATING THE SELF IN CHANDLER,RAYMOND THE 'BIGSLEEP' AND THE 'LONG GOOD-BYE', Studies in the novel, 29(1), 1997, pp. 94-107
Authors:
THORN L
ASHMEADE TE
STOREY VJ
ROUTLEDGE C
REAVILL C
Citation: L. Thorn et al., EVIDENCE TO SUGGEST THAT AGONIST MODULATION OF HYPERLOCOMOTION IS VIAPOSTSYNAPTIC DOPAMINE D-2 OF D-3 RECEPTORS, Neuropharmacology, 36(6), 1997, pp. 787-792
Authors:
ROBERTS C
PRICE GW
GASTER L
JONES BJ
MIDDLEMISS DN
ROUTLEDGE C
Citation: C. Roberts et al., IMPORTANCE OF H5-HT1B RECEPTOR SELECTIVITY FOR 5-HT TERMINAL AUTORECEPTOR ACTIVITY - AN IN-VIVO MICRODIALYSIS STUDY IN THE FREELY-MOVING GUINEA-PIG, Neuropharmacology, 36(4-5), 1997, pp. 549-557
Authors:
ROBERTS C
BELENGUER A
MIDDLEMISS DN
ROUTLEDGE C
Citation: C. Roberts et al., COMPARISON OF 5-HT AUTORECEPTOR CONTROL IN GUINEA-PIG DORSAL AND MEDIAN RAPHE INNERVATED BRAIN-REGIONS, British Journal of Pharmacology, 122, 1997, pp. 207-207
Authors:
TAYLOR SG
PATEL SR
ROBERTS JC
ROUTLEDGE C
Citation: Sg. Taylor et al., REPEATED MICRODIALYSIS EXPERIMENTS IN THE RAT STRIATUM OF CONSCIOUS RATS - EFFECTS OF QUINELORANE ON DOPAMINE RELEASE, British Journal of Pharmacology, 122, 1997, pp. 318-318
Authors:
ROBERTS C
PRICE GW
JONES BJ
MIDDLEMISS DN
GASTER L
ROUTLEDGE C
Citation: C. Roberts et al., IMPORTANCE OF 5-HT1B SELECTIVITY FOR 5-HT TERMINAL AUTORECEPTOR ACTIVITY - AN IN-VIVO MICRODIALYSIS STUDY IN THE FREELY-MOVING GUINEA-PIG, British Journal of Pharmacology, 120, 1997, pp. 140-140
Citation: L. Thorn et C. Routledge, COMPARATIVE MODULATION OF HIPPOCAMPAL 5-HT RELEASE BY THE 5-HT2C RECEPTOR ANTAGONIST SB-206553 AND PAROXETINE, British Journal of Pharmacology, 120, 1997, pp. 257-257
Citation: C. Routledge et al., ELUCIDATION OF D-3 RECEPTOR FUNCTION IN-VIVO - DO D-3 RECEPTORS MEDIATE INHIBITION OF DOPAMINE NEURONAL-ACTIVITY, Biochemical Society transactions, 24(1), 1996, pp. 199-201
Citation: Sg. Taylor et C. Routledge, LACK OF EFFECT OF SYSTEMICALLY ADMINISTERED 5-HT4 AGONISTS ON DOPAMINE LEVELS MEASURED FROM THE NUCLEUS-ACCUMBENS AND STRIATUM - AN IN-VIVOMICRODIALYSIS STUDY IN FREELY-MOVING, British Journal of Pharmacology, 117, 1996, pp. 326-326
Citation: La. Dawson et al., ANALYSIS OF GLUTAMATE IN STRIATAL MICRODIALYSATES USING CAPILLARY ELECTROPHORESIS AND LASER-INDUCED FLUORESCENCE DETECTION, Journal of chromatography, 700(1-2), 1995, pp. 81-87
Authors:
ROUTLEDGE C
GURLING J
ASHWORTHPREECE MA
DOURISH CT
Citation: C. Routledge et al., DIFFERENTIAL-EFFECTS OF WAY-100135 ON THE DECREASE IN 5-HYDROXYTRYPTAMINE RELEASE INDUCED BY BUSPIRONE AND NAN-190, European journal of pharmacology, 276(3), 1995, pp. 281-284
Citation: La. Dawson et C. Routledge, DIFFERENTIAL-EFFECTS OF POTASSIUM CHANNEL BLOCKERS ON EXTRACELLULAR CONCENTRATIONS OF DOPAMINE AND 5-HT IN THE STRIATUM OF CONSCIOUS RATS, British Journal of Pharmacology, 116(8), 1995, pp. 3260-3264
Authors:
ROUTLEDGE C
HARTLEY J
GURLING J
ASHWORTHPREECE M
BROWN G
DOURISH CT
Citation: C. Routledge et al., IN-VIVO CHARACTERIZATION OF THE PUTATIVE 5-HT1A RECEPTOR ANTAGONIST SDZ-216,525 USING 2 MODELS OF SOMATODENDRITIC 5-HT1A RECEPTOR FUNCTION, Neuropharmacology, 33(3-4), 1994, pp. 359-366
Citation: L. Dawson et C. Routledge, EFFECTS OF POTASSIUM CHANNEL BLOCKERS ON EXTRACELLULAR LEVELS OF SEROTONIN AND DOPAMINE IN THE STRIATUM OF CONSCIOUS RATS - A MICRODIALYSISSTUDY, British Journal of Pharmacology, 112, 1994, pp. 210000096-210000096
Authors:
GURLING J
ASHWORTHPREECE MA
DOURISH CT
ROUTLEDGE C
Citation: J. Gurling et al., EFFECTS OF ACUTE AND CHRONIC TREATMENT WITH THE SELECTIVE 5-HT1A RECEPTOR ANTAGONIST WAY-100635 ON HIPPOCAMPAL 5-HT RELEASE IN-VIVO, British Journal of Pharmacology, 112, 1994, pp. 210000152-210000152
Authors:
THOMPSON J
MARSICO T
KATHRYN EL
MAY L
MIDDLETON J
SPEARS G
VAUGHEY BC
KELEHER K
BALDWIN K
FLEMING N
ROUTLEDGE C
SULLIVAN N
STANTON ME
MCDERMOTT J
ULRICH S
WILLIAMS D
NITZSCHE R
STIVERS S
Citation: J. Thompson et al., THE ACNMS VISIONARY PLANNING, Journal of nurse-midwifery, 38(5), 1993, pp. 283-284
Authors:
CLIFFE IA
BRIGHTWELL CI
FLETCHER A
FORSTER EA
MANSELL HL
REILLY Y
ROUTLEDGE C
WHITE AC
Citation: Ia. Cliffe et al., METHOXYPHENYL)-PIPERAZIN-1-YL)-2-PHENYLPROPANAMIDE [(S)-WAY-100135] -A SELECTIVE ANTAGONIST AT PRESYNAPTIC AND POSTSYNAPTIC 5-HT(1A) RECEPTORS, Journal of medicinal chemistry, 36(10), 1993, pp. 1509-1510
Authors:
ROUTLEDGE C
GURLING J
WRIGHT IK
DOURISH CT
Citation: C. Routledge et al., NEUROCHEMICAL PROFILE OF THE SELECTIVE AND SILENT 5-HT(1A) RECEPTOR ANTAGONIST WAY100135 - AN IN-VIVO MICRODIALYSIS STUDY, European journal of pharmacology, 239(1-3), 1993, pp. 195-202